News

Pharmabiz9m
Veranova appoints Thomas Rohrer as vice president of bioconjugation
Veranova appoints Thomas Rohrer as vice president of bioconjugation: Devens, Massachusetts Wednesday, July 30, 2025, 16:00 ...
Pharmabiz2h
Govt. Schemes helped growth of medical devices exports to 88% in six years: Centre
The Schemes supporting development and manufacturing of medical devices in the country have helped growth of medical devices exports from the country to almost 88% during six financial years upto 2024 ...
Pharmabiz2h
A culture of quality excipients has ushered in: Experts at IPEC India Annual Conference
A culture of quality excipients has ushered in as the pharmaceutical industry advances towards manufacturing super and complex generics which requires high precision levels of process controls, Good ...
Pharmabiz2h
Indian nutraceutical companies grapple with a maze of global regulatory challenges
Indian nutraceutical companies are increasingly looking to expand into global markets, but navigating the complex web of international regulations poses a significant hurdle. The industry sees the ...
Pharmabiz2h
DGTR initiates anti-dumping probe on imports of “Bromo OTBN” from China
Aimed at safeguarding domestic industry interests, the Directorate General of Trade Remedies (DGTR) has initiated anti-dumping investigation on imports of “4-(Bromomethyl)-2'-cyanobiphenyl”, commonly ...
Pharmabiz4h
Agilent supports India’s global biopharma ambitions with state-of-the-art experience center in Hyderabad
Agilent supports India’s global biopharma ambitions with state-of-the-art experience center in Hyderabad: Our Bureau, ...
Pharmabiz40m
Haleon partners with Indian Dental Association to inaugurate the first D20 International Symposium
Haleon partners with Indian Dental Association to inaugurate the first D20 International Symposium: Our Bureau, Mumbai Wednesday, July 30, 2025, 15:30 Hrs [IST] Haleon (erstwhile ...
Pharmabiz2h
Genethon gets UK MHRA nod to initiate pivotal phase 3 trial of GNT0004, a low-dose microdystrophin gene therapy for Duchenne muscular dystrophy
Genethon gets UK MHRA nod to initiate pivotal phase 3 trial of GNT0004, a low-dose microdystrophin gene therapy for Duchenne muscular dystrophy: Paris, France Wednesday, July 30, ...
Pharmabiz1h
US FDA approves PTC Therapeutics’ Sephience to treat children and adults living with phenylketonuria
US FDA approves PTC Therapeutics’ Sephience to treat children and adults living with phenylketonuria: Warren, New Jersey Wednesday, July 30, 2025, 15:00 Hrs [IST] PTC Therapeuti ...
Pharmabiz1h
Bausch Health to acquire DURECT Corporation, strengthening commitment to developing innovative solutions for patients with liver disease
Bausch Health to acquire DURECT Corporation, strengthening commitment to developing innovative solutions for patients with liver disease: Laval, Quebec Wednesday, July 30, 2025, 1 ...
Pharmabiz8h
Seminar on revised Schedule M at JIS University in Kolkata emphasizes urgent GMP compliance in Indian pharma
Peethaambaran Kunnathoor, Chennai Wednesday, July 30, 2025, 08:00 Hrs [IST] ...
Pharmabiz3h
Ofichem expands drug substance capabilities with acquisition of Meribel Pharma Solutions’ Uppsala site in Sweden
Ofichem expands drug substance capabilities with acquisition of Meribel Pharma Solutions’ Uppsala site in Sweden: Ter Apel, Netherlands Wednesday, July 30, 2025, 13:00 Hrs [IST] ...